✨ Your Portfolio is fetched and updated from zerodha.
Small Chemicals

Epigral Ltd.

EPIGRAL

Market Cap
₹7,767 Cr.
P/E
21.72

Epigral Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
7,767 Cr
PE
PE
21.72
Prom Holding
Prom Holding
68.95 %
ROE (%)
ROE (%)
18.78
ROCE (%)
ROCE (%)
22.31
Div Yield (%)
Div Yield (%)
0.61
Sales
Sales
2,550 Cr
OPM (%)
OPM (%)
27.87 %
Debt to Equity
Debt to Equity
0.31
View more
Edit Ratio's
About
Epigral Limited (Formerly known as Meghmani Finechem Limited) is primarily engaged in manufact… Read more
Low
1341
52W Range
High
2407
  • Epigral
  • DCM Shriram
  • Guj. Alkalies & Chem

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

11 Yes

Positive for this company

1 Neutral

Neutral for this company

4 No

Negative for this company

1 No Data

Insufficient data to analyse

Market Share
0 %
(as of Mar 22)
Source/Historic
Chlor-Alkalis - Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • Capacity Utilization - Chemicals (%)
      Source
    • Manufacturing Capacity - Caustic Soda (MTPA)
      Source
    • Realization / Tonne - Caustic Soda (Rs/MT)
      Source
    • Manufacturing Capacity - Chloromethanes (MTPA)
      Source
    • Manufacturing Capacity - Hydrogen Peroxide (MTPA)
      Source
    • Capacity Utilization - Chlor-Alkali (%)
      Source
    • Manufacturing Capacity - Caustic Potash (MTPA)
      Source
    • Manufacturing Capacity - CPVC Resin (MTPA)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Epigral Ltd. Business

    Epigral Limited, formerly known as Meghmani Finechem Limited, is a leading ISO-certified company manufacturing and selling Chlor Alkali & its Derivatives with backward and forward integration facilities.

    Epigral major competitors are DCM Shriram, Guj. Alkalies & Chem, Chemfab Alkalis, TGV SRACC, TN Petro Products, Primo Chemicals, Lords Chloro Alkali.
    Market Cap of Epigral is ₹7,767 Crs.
    While the median market cap of its peers are ₹1,047 Crs.

    Epigral seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice
    Company Filing
    Discussions & Analysis
    Epigral Ltd.
    From Commodity to Specialty Chemicals - Meghmani Finechem - Logical Investor
    Corporate Governance Red Flags At Meghmani - Logical Investor
    Value Chain - Meghmani Finechem - Dr Prashanth Mishra
    Epigral Ltd: How this chemical company is replacing Chinese Imports - Green Portfolio
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material